Voquezna 10 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB26FATZY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,955
Award facts
- Contract value 100% obligated
- $3,954.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,954.76 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Voquezna 10 mg tablets (30-count package). The award was issued on October 29, 2025, with an ultimate completion date of October 30, 2025, under a firm fixed-price contract type with no set-aside designation. The product will be delivered to Conshohocken, PA. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for Department of Defense healthcare operations.
DMS Pharmaceutical Group serves as a critical pharmaceutical supplier within the federal military medical supply chain, leveraging its small business status to compete effectively while maintaining consistent performance across diverse product categories. The company's established track record includes the distribution of specialty pharmaceuticals, biologics, vaccines, and medical consumables to military healthcare facilities. Under the PPV-G GEN V contract—which carries a ceiling value of $499.99 million and extends through December 31, 2036—DMS Pharmaceutical Group is positioned to fulfill recurring pharmaceutical requirements for DoD healthcare operations globally, with this Voquezna order representing routine pharmaceutical supply operations within that broader contractual framework.
Quick answers
Who was awarded contract SPE2DB26FATZY?
SPE2DB26FATZY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FATZY worth?
The government has obligated $3,955 on SPE2DB26FATZY.
Is contract SPE2DB26FATZY an order under another contract?
Yes. SPE2DB26FATZY is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB26FATZY competed?
The extent of competition for SPE2DB26FATZY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award